Navigation Links
New Vaccine May Work Better Against Lung Disease
Date:9/9/2009

Different formulation seems to thwart pneumonia in high-risk group with COPD, study finds

WEDNESDAY, Sept. 9 (HealthDay News) -- A recently developed pneumonia vaccine may be more effective in preventing infections in patients with chronic obstructive pulmonary disease (COPD) than the vaccine that is typically used, new research suggests.

Risk of pneumonia can be an ongoing problem for people with COPD, a chronic, progressive disease that causes difficulty breathing and chest tightness. The U.S. Centers for Disease Control and Prevention recommends that all adults with COPD be vaccinated against pneumonia with a vaccine referred to as PPSV23 (23-valent pneumococcal polysaccharide vaccination).

But the effectiveness of the vaccine in people with COPD hasn't been sufficiently proven, according to the study that will appear in the Sept. 15 issue of the American Journal of Respiratory and Critical Care Medicine.

"Reasonable effectiveness for this vaccine has been demonstrated in cohort studies in adults with lung disease," said study author Dr. Mark Dransfield of the University of Alabama at Birmingham, in a news release from the American Thoracic Society. "[However,] debate remains about its immunogenicity and effectiveness in COPD."

In the current study, researchers inoculated 120 adults with moderate to severe COPD with either PPSV23 or a newer vaccine, PCV7.

Several indicators showed the PCV7 vaccine produced a heightened immune response as compared to the older vaccine.

The blood of patients who had received PCV7 vaccine was also more effective at killing pneumonia-causing bacteria in six of seven serotypes, or groups of microorganisms, one month after vaccination, the researchers found.

"We have shown that PCV7 induces a superior immune response to PPSV23 in COPD at one month post-vaccination," Dransfield stated in the news release.

However, older age and prior vaccination with PPSV23 blunted the efficacy of the PCV7 vaccine, the researchers noted, and further study is needed.

More information

The National Heart, Lung, and Blood Institute has more on COPD.



--Jennifer Thomas



SOURCE: American Thoracic Society, news release, Sept. 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Panel Weighs Approving HPV Vaccine for Males
2. Vaxart Awarded NIH Grant to Support Development of Orally-Delivered H5N1 Avian Influenza Vaccine
3. Offits Failure to Disclose Jeopardizes Swine Flu Vaccine Program
4. Swine Flu Vaccine Seems Safe: Experts
5. Discoveries Brighten Search for AIDS Vaccine
6. HPV vaccine could prevent breast cancer: Australian research
7. Pennsylvania Department of Health Launches Online H1N1 Vaccine Registry
8. Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine?
9. Sinovacs H1N1 Vaccine Passes Experts Evaluation Organized by SFDA
10. IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests
11. Sinovac Wins Beijing Public Health Bureaus Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Vaccine May Work Better Against Lung Disease
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology: